26 August 2022 World India: Sub-Standard Medicines Threaten The Goal Of Zero Malaria Fraudulent and sub-standard antimalarials drive up case numbers, suffering and death. They are the main obstacle as India pursues malaria eradication by 2030.
22 June 2020 Malaysia Malaysia Drops Hydroxychloroquine From Covid-19 Treatment MOH requires more data to study the effectiveness of potential Covid-19 medicines, but Malaysia currently doesn’t have enough cases.
18 June 2020 World Hydroxychloroquine Dropped From WHO Covid-19 Trial Data from the Solidarity trial and another study suggested the antimalarial drug would not be beneficial.
9 June 2020 Malaysia Malaysia Finds Hydroxychloroquine Can Slow Covid-19 Progress MOH will reveal the effectiveness of hydroxychloroquine in treating Covid-19 after completing a study on Malaysian hospitals.
5 June 2020 World Lancet Retracts Major Study On Safety Of Antimalarials For Covid-19 US-based data company, Surgisphere, refused cooperation with independent auditors.
7 April 2020 Malaysia Antimalarial Drug Helped Stop Covid-19 Patients From Worsening: DG A whopping 88% of Malaysia’s coronavirus cases are in the first two early stages.